Results 121 to 130 of about 3,200 (166)

Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies. [PDF]

Oncoimmunology
Truntzer C, Thibaudin M, Bousquet PA, Peroz M, Derangère V, Ilie A, Rageot D, Flatmark K, Ree AH, Meltzer S, Ghiringhelli F.   +10 more
europepmc   +1 more source

Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1. [PDF]

J Immunother Cancer
Middleton G, Gaskell C, Savage J, Bridgewater J, Ross P, Saunders M, Palmer D, Plummer R, Clive S, Coyle V, Thomas A, Cunningham D, Taniere P, Billingham L.   +13 more
europepmc   +1 more source

KIF18A inhibitor prevents chromosomally unstable osteosarcoma growth by activating spindle assembly checkpoint. [PDF]

Cancer Biol Ther
Yan Q, Zhang Y, Wang P, Fu Y, Ke C, Han S, Xing J, Li H, Zhang K.   +8 more
europepmc   +1 more source

PatchSight-ImmuneMap-LifeSpan as a unified AI framework for breast cancer diagnosis, immune profiling and prognostic prediction. [PDF]

Discov Oncol
Al-Nussairi AKJ, Ali ABM, Malik S, Patro SGK, Mahanty C, Abass KS, Basheti I, Dessalegn AA, Muzammil K, Kumar S.   +9 more
europepmc   +1 more source

Digital Pathology and the AI-Based Quantification of the Tumor Microenvironment in Gastrointestinal Cancer: From Tumor Budding and Tumor-Infiltrating Lymphocytes to Tertiary Lymphoid Structures. [PDF]

Int J Mol Sci
Łapińska J, Kasperczuk K, Kańczugowska K, Gałan A, Pająk W, Kleinrok J, Sitarz R, Baj J, Korolczuk A.   +8 more
europepmc   +1 more source

Immunoscore Predicted by Dynamic Contrast-Enhanced Computed Tomography Can Be a Non-Invasive Biomarker for Immunotherapy Susceptibility of Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Ueshima E, Sofue K, Komatsu S, Ishihara N, Komatsu M, Umeno A, Nishiuchi K, Kozuki R, Yamaguchi T, Matsuura T, Tada T, Murakami T.   +11 more
europepmc   +1 more source

Evaluation of short-course durvalumab combined with dose-dense EC in the neoadjuvant setting for locally advanced luminal B/HER2(-) or triple-negative breast cancer. [PDF]

Breast Cancer Res
Devaux A, Beniuga G, Delrée P, Quaghebeur C, Henry S, Van Bockstal M, Galant C, Lefevre S, Korman D, Verschaeve V, Lonchay C, D'Hondt L, Berlière M, van Marcke C, Delmarcelle S, Mine JM, Müller G, Myant N, Bar I, Haussy S, Merhi A, Petrone D, Coulie PG, Canon JL, Duhoux FP, Carrasco J.   +25 more
europepmc   +1 more source

Definition of different types of immune infiltrates: immunoscore

Report on the defintion of the different types of immune ...
openaire   +1 more source

Hijacking erythropoietin: A tumour-intrinsic strategy to escape immune surveillance. [PDF]

Clin Transl Med
Chiu DK, Engleman EG.
europepmc   +1 more source

Immunoscore and Microbiome in Colorectal Cancer: What’s New?

, 2019
Filipa Macedo, Nuno Bonito, Adhemar Longatto-Filho, Sandra F. Martins   +3 more
openaire   +2 more sources